Atossa Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Atossa Therapeutics

11/08/2022 13:00

* Atossa Therapeutics Inc  ATOS.OQ  reported a quarterly
adjusted
loss of 5 cents​​ per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was for a loss
of 6 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Atossa Therapeutics Inc's reported EPS for the quarter was
a
loss of 5 cents​.
    * The mean earnings estimate of analysts had fallen by
about 9.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Atossa Therapeutics Inc shares had fallen by 3.7% this
quarter and lost 34.4% so far this year.
    * The company reported a quarterly loss of $6.67 million.
    * Wall Street's median 12-month price target for Atossa
Therapeutics Inc is $5.75 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 11
at 12:00 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.06          -0.05          Beat
 Mar. 31 2022      -0.05          -0.04          Beat
 Dec. 31 2021      -0.04          -0.04          Met
 Sep. 30 2021      -0.04          -0.04          Met